Protalix BioTherapeutics
PLX
PLX
65 hedge funds and large institutions have $18M invested in Protalix BioTherapeutics in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 7 closing their positions.
Holders
65
Holders Change
+4
Holders Change %
+6.56%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
21
Reduced
16
Closed
7
Calls
$984K
Puts
$150K
Net Calls
+$834K
Net Calls Change
-$184K
Top Buyers
1 |
1
Morgan Stanley
New York
|
$888K |
2 |
2
BlackRock
New York
|
$6.15M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$184K |
4 |
4
Northern Trust
Chicago,
Illinois
|
$880K |
5 |
5
Barclays
London,
United Kingdom
|
$224K |